Nutritional Transition in the Maghreb and Prevention of Obesity and Non-communicable Diseases

NCT ID: NCT01844349

Last Updated: 2013-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8218 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-03-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Problematic and state of the art Obesity and its associated non communicable diseases (NCDs) are rising rapidly in middle income countries, such as those in the Maghreb (North Africa). This progression is related to the context of a nutrition transition (changing food and physical activity environment) and profound changes in technological advances and in society. These societies and their health systems are insufficiently prepared for this evolution, which has enormous health and socioeconomic consequences. In the context of limited resources, the priority has been given on an international level to prevention. But several problems arise: - these countries are still confronted by undernutrition in terms of micronutrient deficiencies, which coexist with obesity and NCDs, including at a family level and also individual level. Known as the 'double burden', this coexistence is relatively new and has been rarely documented until recently. Educational measures could be ineffective in a society where cultural norms do not recognise obesity and where changes in lifestyle are possibly not seen as acceptable. As well as information about citizen's knowledge of risk factors, data on their perceptions and attitudes are indispensable. Policies that involve changing the 'obesogenic' environment that individuals occupy is a priority.

Objectives of the project Overall aim: to contribute to the development of preventive strategies for obesity and chronic NCDs in the context of a nutrition transition.

Specific objectives: characterise the nature and size of the double burden (obesity/undernutrition) in regions, families and individuals; estimate the prevalence of biological and behavioural risk factors; characterise the psycho-sociocultural determinants of behaviour.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiency, Anaemia, Overweight, Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* To live in the region of the capital city
* To give free informed consent

Exclusion Criteria

* Pregnancy
Minimum Eligible Age

6 Months

Maximum Eligible Age

49 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agnes GARTNER

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Agnes GARTNER

Researcher

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Agnes Gartner, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute of Research for Development

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Sciences, Ibn Tofaïl University

Kenitra, Rabat-Salé, Morocco

Site Status

National Institute of Nutrition and Food Technology (INNTA)

Tunis, Great Tunis, Tunisia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Morocco Tunisia

References

Explore related publications, articles, or registry entries linked to this study.

Ben Cherifa F, El Ati J, Doggui R, El Ati-Hellal M, Traissac P. Prevalence of High HDL Cholesterol and Its Associated Factors Among Tunisian Women of Childbearing Age: A Cross-Sectional Study. Int J Environ Res Public Health. 2021 May 20;18(10):5461. doi: 10.3390/ijerph18105461.

Reference Type DERIVED
PMID: 34065252 (View on PubMed)

Sassi S, Abassi MM, Traissac P, Ben Gharbia H, Gartner A, Delpeuch F, El Ati J. Intra-household double burden of malnutrition in a North African nutrition transition context: magnitude and associated factors of child anaemia with mother excess adiposity. Public Health Nutr. 2019 Jan;22(1):44-54. doi: 10.1017/S1368980018002495. Epub 2018 Oct 9.

Reference Type DERIVED
PMID: 30298796 (View on PubMed)

Traissac P, El Ati J, Gartner A, Ben Gharbia H, Delpeuch F. Gender inequalities in excess adiposity and anaemia combine in a large double burden of malnutrition gap detrimental to women in an urban area in North Africa. Public Health Nutr. 2016 Jun;19(8):1428-37. doi: 10.1017/S1368980016000689. Epub 2016 Apr 6.

Reference Type DERIVED
PMID: 27049694 (View on PubMed)

Gartner A, El Ati J, Traissac P, Bour A, Berger J, Landais E, El Hsaini H, Ben Rayana C, Delpeuch F. A double burden of overall or central adiposity and anemia or iron deficiency is prevalent but with little socioeconomic patterning among Moroccan and Tunisian urban women. J Nutr. 2014 Jan;144(1):87-97. doi: 10.3945/jn.113.178285. Epub 2013 Nov 6.

Reference Type DERIVED
PMID: 24198310 (View on PubMed)

Gartner A, Berger J, Bour A, El Ati J, Traissac P, Landais E, El Kabbaj S, Delpeuch F. Assessment of iron deficiency in the context of the obesity epidemic: importance of correcting serum ferritin concentrations for inflammation. Am J Clin Nutr. 2013 Sep;98(3):821-6. doi: 10.3945/ajcn.112.054551. Epub 2013 Jul 24.

Reference Type DERIVED
PMID: 23885047 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Corus 6028-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Body Weight and Vascular Function
NCT01675401 COMPLETED NA
Executive Function in Obese
NCT06578091 RECRUITING